The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
about
Tyrosine hydroxylase and regulation of dopamine synthesisIron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesSubstantia nigra neuromelanin: structure, synthesis, and molecular behaviourInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseBax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseA monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysUpdate on the treatment of Parkinson’s disease psychosis: role of pimavanserinNeurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's diseaseDJ-1 is critical for mitochondrial function and rescues PINK1 loss of function.Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protectionComparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes.DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.If you assume, you can make an ass out of u and me': a decade of the disector for stereological counting of particles in 3D spaceUsing 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Clinical progression in Parkinson disease and the neurobiology of axons.A novel approach to non-biased systematic random sampling: a stereologic estimate of Purkinje cells in the human cerebellum.Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's diseaseStereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellumCell survival and clinical outcome following intrastriatal transplantation in Parkinson disease.Genetics of parkinsonism.Intracellular signalling pathways in dopamine cell death and axonal degeneration.The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons.α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson diseaseProteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseCan Parkinson's disease be cured by stimulating neurogenesis?The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairmentProgression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses.Characterization of kinases involved in the phosphorylation of aggregated α-synuclein.Pathologic and immunohistochemical findings in hypothalamic and mesencephalic regions in the pah(enu2) mouse model for phenylketonuria.The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.Axon degeneration in Parkinson's diseaseAdministration of thimerosal-containing vaccines to infant rhesus macaques does not result in autism-like behavior or neuropathologyPitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Morphometry of the human substantia nigra in ageing and Parkinson's disease.
P2860
Q21710723-46EE71CA-3277-4019-869B-4ED1A4014EEDQ22337213-9FDB6F21-9918-4E54-BCDC-2C8BE0D784BDQ28365463-6E9C5B67-3362-437A-9CA1-0EEDB4E4C8C9Q28391762-1DCAB2D7-BC34-42CC-9B79-D34D5061ABDAQ28594269-0435AB1B-2DD6-4A63-9079-483EDCE3DA67Q28728201-F924DE32-EE47-4014-9DDE-58A5516633BDQ29048641-073FDA92-1474-40FD-8DCD-BF6687AC3307Q29619506-CA7C14A6-E64C-47CA-9959-9ED1BBBB2509Q30495575-A2D58E40-F407-4D2B-87AD-FAC098AF6D0EQ31172552-AB088860-1338-4BA4-A650-58C78A09D651Q32160990-8919C864-7350-47A4-85C4-53F7C9242ABDQ33183865-431D2851-78A2-41B4-BA4C-642072293CEDQ33755817-138DC834-9C6C-48EC-BF83-E23B4AA75A7CQ33881919-93C749F8-82CC-4457-935A-0BA544CAB404Q34032608-5EEBB57A-4C37-4531-BC34-678F3B2F7D4BQ34052764-D4A7A8B9-856C-45BD-AF69-38F90E01397BQ34082426-89F8BAD6-BBC5-448B-B3A8-D1A9CC4DAB96Q34181259-C7EC0B60-37D1-43B0-8A44-D166BB6DA530Q34254256-53218E65-FFEF-4EF6-B89A-A7D1DDD3208FQ34327144-F7CC20D0-C082-4CDF-AA42-2B7F1B72FA98Q34811944-3BE08399-7A35-49D6-A5AB-00F0812152EBQ34936423-AD7145E2-C1C5-4AEE-BA25-094AA9831FB2Q35050577-ED7173F3-B4E1-4249-9C76-994402D34601Q35100189-ADBD6608-A380-4422-B28B-E3E78C258FE2Q35125001-45ECD30D-F435-4023-9610-D311BF90E7F8Q35183991-02DEF0D0-771E-4491-BBDA-41596717BABDQ35196195-EA1B1AE2-601D-4040-828E-A87FC5213C5BQ35212580-7670BFF2-9964-41DA-A8E5-39C2F8B53149Q35266392-C4F6B300-5ED0-4F06-ADBC-62E2E83107EDQ35474206-27DC8AF8-B243-4C33-9233-902A7101436EQ35648129-2BF8A420-8583-4B6D-A405-7F018E10DC7CQ35692168-0D5D2F81-3BF6-4A44-8A20-748B931E5A06Q35795019-66432461-FB4F-4FE2-848A-95F2F2452ECFQ35810261-020ADE21-2566-4944-A3B7-793B7C812883Q35894167-2CF058E5-A859-4761-8FF2-8F699A2AA454Q35923102-2A53C9B2-8370-499A-BD52-BB22EB220141Q36155191-B65A9810-1096-435D-B857-DE0492B89BBBQ36271380-0D767089-8EB2-48A8-8117-3D8A68FF90B2Q36503887-CE419123-22EF-4106-8223-E46D410526D4Q36727465-8C7CAF80-519E-4A20-9346-2073C80D4612
P2860
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The absolute number of nerve c ...... unbiased stereological method
@ast
The absolute number of nerve c ...... unbiased stereological method
@en
The absolute number of nerve c ...... unbiased stereological method.
@nl
type
label
The absolute number of nerve c ...... unbiased stereological method
@ast
The absolute number of nerve c ...... unbiased stereological method
@en
The absolute number of nerve c ...... unbiased stereological method.
@nl
prefLabel
The absolute number of nerve c ...... unbiased stereological method
@ast
The absolute number of nerve c ...... unbiased stereological method
@en
The absolute number of nerve c ...... unbiased stereological method.
@nl
P2093
P2860
P921
P356
P1476
The absolute number of nerve c ...... unbiased stereological method
@en
P2093
Gundersen HJ
Mouritzen Dam A
Pakkenberg B
Pakkenberg H
P2860
P356
10.1136/JNNP.54.1.30
P407
P577
1991-01-01T00:00:00Z